Fast-acting insulin aspart (faster aspart) is insulin aspart (IAsp) with two added excipients, l-arginine and niacinamide, to ensure formulation stability with accelerated initial absorption after subcutaneous administration compared with previously developed rapid-acting insulins. The pharmacokinetic/...
insulin as·part -ˈas-ˌpärt : a short-acting recombinant form of insulin administered by subcutaneous injection in the treatment of type 1 and type 2 diabetes Note: Insulin aspart is marketed under the trademark NovoLog. Dictionary Entries Near insulin aspart insulinase insulin ...
产品名称Insulin aspart 别名门冬胰岛素 规格或纯度≥95% 生化机理天冬胰岛素(B28Asp)是人胰岛素的速效类似物。与普通人用胰岛素相比,天冬胰岛素皮下注射后吸收更快。天冬胰岛素可用于研究糖尿病。 产品介绍 Insulin aspart (B28Asp) is a fast-acting analog of human insulin. Insulin aspart provides more rapid ...
To study the pharmacokinetic and pharmacodynamic profile of insulin aspart (a new fast-acting human insulin analog) after subcutaneous administration in the deltoid, abdominal, and thigh sites and to compare this profile with regular human insulin (Novolin; Novo Nordisk A/S, Copenhagen).A total of...
Long-term efficacy and safety of insulin detemir compared to Neutral Protamine Hagedorn insulin in patients with Type 1 diabetes using a treat-to-target ba... Aims This 24-month, multi-national, open-label, parallel group trial investigated the long-term efficacy and safety of insulin detemir ...
The new fast-acting insulin aspart (faster aspart) is a novel formulation of insulin aspart that contains 2 additional excipients: nicotinamide (vitamin B3) and L-arginine. Nicotinamide is responsible for faster absorption by increasing the initial abundance of insulin aspart monomers in the subcutaneo...
Raskin P, McGill J, Kilo C, et al. Human insulin analog (insulin aspart, IAsp) is comparable to human insulin (HI) in type 2 diabetes [abstract]. Diabetes 1999; 48 Suppl. 1: A355 Google Scholar Raskin P, Guthrie RA, Leiter L, et al. Use of insulin aspart, a fast-acting insulin...
NovoLog®starts acting fast.Eat a meal within 5 to 10 minutes after taking it. Know the type and strength of your insulin.Do notchange your insulin type unless your health care provider tells you to. Check your blood sugar levels.Ask your health care provider what your blood sugar levels...
NovoLog®starts acting fast.Eat a meal within 5 to 10 minutes after taking it. Know the type and strength of your insulin.Do notchange your insulin type unless your health care provider tells you to. Check your blood sugar levels.Ask your health care provider what your blood sugar levels...
A biosimilar of the fast-acting, meal-timeinsulin lisproHumalog(Lilly) is approved in the European Union, where it is known as Insulin lispro Sanofi. The same product is approved in the United States, where it is known asAdmelog. Until recently, such products were called "follow-ons" in ...